Colorectal Cancer
- Cancer PHGKB -
What's New
Last Posted: Dec 24, 2020
- Pandemic Spotlights In-home Colon Cancer Screening Tests
MC Jaclevic, JAMA, December 23, 2020 - A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer.
Chu Haiyan et al. Environment international 2020 Dec 147106309 - Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.
Jensen Benny V et al. International journal of cancer 2020 Dec - Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review.
Unanue-Arza Saloa et al. European journal of public health 2020 Dec - Population-based Screening for Hereditary Colorectal Cancer Variants in Japan.
Fujita Masashi et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Dec - Application of artificial intelligence to the diagnosis and therapy of colorectal cancer.
Wang Yutong et al. American journal of cancer research 2020 10(11) 3575-3598 - Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens.
Marks Eric I et al. American journal of clinical oncology 2020 Dec - Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
T Andre et al, NEJM, December 2, 2020 - Pembrolizumab in MSI-H–dMMR Advanced Colorectal Cancer — A New Standard of Care
A Grothey, NEJM, December 2, 2020 - Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments.
Bruera Gemma et al. Pharmacogenomics and personalized medicine 2020 13601-617 - Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer.
Moosavi Sarvee et al. Journal of the Canadian Association of Gastroenterology 2020 Dec 3(6) 288-292 - New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients.
Djursby Malene et al. Frontiers in genetics 2020 11566266 - Rising incidence of early-onset colorectal cancer - a call to action.
Akimoto Naohiko et al. Nature reviews. Clinical oncology 2020 Nov - Testing for lynch syndrome in people with endometrial cancer using immunohistochemistry and microsatellite instability-based testing strategies - A systematic review of test accuracy.
Stinton Chris et al. Gynecologic oncology 2020 Oct - Spectrum of mutations in genes associated with familial colorectal cancer syndrome (MLH1, MSH2, PMS2, MSH6, and APC): A not so common hereditary cancer syndrome in Indian population.
Bhai Pratibha et al. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2020 Nov
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic discoveries into improved health care and prevention related to cancer...more
Content Summary
- CDC Information (19)
- NIH Information (9)
- COVID-19 (10)
- CDC Genomics Publications (10)
- Human Genome Epidemiologic Studies (4796)
- GWAS Studies (55)
- Human Genomics Translation/Implementation Studies (764)
- Genomic Tests Evidence Synthesis (115)
- Genomic Tests Guidelines (58)
- Tier-Classified Guidelines (25)
- Non-Genomics Precision Health (44)
- Pathogen Advanced Molecular Detection (16)
- State Public Health Genomics Programs (38)
- Reviews/Commentaries (332)
- Tools/Methods (14)
- Ethical/Legal and Social Issues (ELSI) (2)
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 28, 2020
- Content source: